The majority of organizations (76 percent) provide GLP-1 drug coverage for diabetesthe original intended use for drugs including Ozempicfar outpacing the percentage of those providing coverage for weight loss, according to a new survey of 200 employers out from the International Foundation of Employee Benefit Plans (IFEBP)
Mar 1, 2026 You are wasting up to half of every dose
Most cells obtain cysteine from the cystine/glutamic acid reverse transporter system Xc-, which includes solute carrier family 7 member 11 (SLC7A11, also known as xCT) and solute carrier family 3 member 2 (SLC3A2, also known as CD98)
Lateral epicondylitis (tennis elbow), Achilles tendinopathy, and patellar tendinopathy are the three chronic conditions discussed in anecdotal BPC-157 reports among athletes and practitioners, though none are backed by completed human trials
NichollsSJBhattDLBuseJBPratoSDKahnSELincoffAMet alComparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics